Komipharm International Co. Ltd (041960) — Cash Flow Reinvestment Rate
Komipharm International Co. Ltd (041960) has a Cash Flow Reinvestment Rate of 5.10x as of December 2025, reinvesting ₩4.83 Billion (capex ₩1.85 Billion plus investments ₩2.98 Billion) from operating cash flow of ₩946.94 Million. Check how high is Komipharm International Co. Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Komipharm International Co. Ltd Cash Flow Reinvestment Rate (2013–2024)
Historical reinvestment intensity for Komipharm International Co. Ltd across 6 annual periods. Explore Komipharm International Co. Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Komipharm International Co. Ltd (2013–2024)
Year-by-year capital reinvestment analysis for Komipharm International Co. Ltd. For live market cap and broader valuation context, see 041960 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.67x | ₩5.96 Billion | ₩8.85 Billion | ₩3.98 Billion | ▼ -99.1% |
| 2020 | 76.26x | ₩1.92 Billion | ₩25.20 Million | ₩1.66 Billion | ▲ +1149.9% |
| 2019 | 6.10x | ₩5.80 Billion | ₩950.79 Million | ₩5.74 Billion | ▼ -57.5% |
| 2017 | 14.35x | ₩3.38 Billion | ₩235.64 Million | ₩2.68 Billion | ▲ +5.5% |
| 2016 | 13.60x | ₩16.43 Billion | ₩1.21 Billion | ₩12.24 Billion | ▲ +114.6% |
| 2013 | 6.34x | ₩24.93 Billion | ₩3.93 Billion | ₩24.93 Billion | — |